LINALIGOLD M 2.5/850 : Suggests control over blood glucose levels......

Jul 29, 2024

LINALIGOLD M 2.5/850 

Metformin (850mg) & Linagliptin (2.5mg)

LINALIGOLD M 2.5/850 is an advanced medication that combines Metformin 850 mg with Linagliptin 2.5 mg to provide effective management of type 2 diabetes. This combination offers a comprehensive approach to controlling blood sugar levels by leveraging the benefits of both drugs.

Metformin (850 mg)

Metformin is a first-line treatment for type 2 diabetes and works through several key mechanisms:

  • Enhanced Insulin Sensitivity: Improves the body's ability to use insulin effectively, lowering blood glucose levels.
  • Reduction of Hepatic Glucose Production: Decreases the liver’s glucose output, which helps in controlling overall blood sugar levels.

Linagliptin (2.5 mg)

Linagliptin is a DPP-4 inhibitor that complements Metformin’s action by:

  • Increasing Insulin Release: Promotes the release of insulin from the pancreas in response to high blood sugar levels.
  • Decreasing Glucagon Levels: Lowers glucagon, a hormone that increases glucose production in the liver, thus helping to stabilize blood sugar levels.

Benefits of LINALIGOLD M 2.5/850

  • Dual Mechanism: Combines two different mechanisms of action for comprehensive glucose control, addressing multiple aspects of diabetes management.
  • Effective Glycemic Control: Helps maintain stable blood glucose levels, reducing the risk of complications associated with uncontrolled diabetes.
  • Convenience: Provides a simplified treatment regimen with a single pill combining both medications, improving adherence to therapy.

Dosage and Administration

  • Initial Dose: Typically, one tablet of LINALIGOLD M 2.5/850 is taken once daily with a meal to help reduce gastrointestinal side effects.
  • Adjustments: Dosage may be adjusted based on individual patient needs and tolerability. Regular monitoring of blood glucose levels is essential for optimizing therapy.
  • Administration: The tablet should be taken whole and not chewed or crushed. It is important to follow the prescribed schedule and consult a healthcare provider before making any changes to the dosage.

Potential Side Effects

Patients taking LINALIGOLD M 2.5/850 may experience:

  • Common Side Effects: Digestive issues such as nausea and diarrhea, as well as headaches.
  • Serious Side Effects: Though rare, there is a risk of lactic acidosis with Metformin, and hypoglycemia may occur with Linagliptin, particularly if combined with other diabetes medications.

Cost and Accessibility

The cost of LINALIGOLD M 2.5/850 may vary depending on the pharmacy and location, but it is generally priced to be accessible for most patients requiring combination therapy for diabetes.

Conclusion

LINALIGOLD M 2.5/850 represents an effective solution for managing type 2 diabetes by combining the beneficial effects of Metformin and Linagliptin. Its dual-action approach offers comprehensive blood glucose control, making it a valuable option for patients looking to enhance their diabetes management strategy. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.

For further information 

Email: info@sterispharma.com /  contact@sterispharma.com

Call/WhatsApp:  7877551268, 7849827488 

BUY NOW

SHARE WITH